Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT02682667 ·Status: RECRUITING

Molecular Analysis of Thoracic Malignancies

NCT01385722 ·Status: ENROLLING_BY_INVITATION

A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments

NCT00586417 ·Status: TERMINATED ·Phase: NA

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069 ·Status: RECRUITING

Microscopy Imaging of Whole-mount Stained Human Tissues

NCT05689112 ·Status: RECRUITING

Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

NCT06630273 ·Status: NOT_YET_RECRUITING

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

NCT00899496 ·Status: COMPLETED

Immunobiology of Cancer

NCT00767533 ·Status: TERMINATED

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

NCT00004153 ·Status: COMPLETED ·Phase: NA

A Multicenter Cancer Biospecimen Collection Study

NCT04510129 ·Status: RECRUITING

A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer

NCT05338060 ·Status: COMPLETED

Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells

NCT00020072 ·Status: COMPLETED ·Phase: NA

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

NCT00904514 ·Status: TERMINATED

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

NCT05600933 ·Status: ENROLLING_BY_INVITATION

Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors

NCT05683353 ·Status: ACTIVE_NOT_RECRUITING

Study of Tissue and Blood Samples From Patients With High-Grade Glioma

NCT01004887 ·Status: COMPLETED

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

NCT00568490 ·Status: RECRUITING

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

NCT06827639 ·Status: NOT_YET_RECRUITING

Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

NCT05869994 ·Status: WITHDRAWN

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

NCT00897481 ·Status: UNKNOWN

Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

NCT05083494 ·Status: UNKNOWN

Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer

NCT00899860 ·Status: TERMINATED

Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496

NCT00898963 ·Status: COMPLETED

Immune Biomarker Study for Head and Neck Cancer

NCT05375266 ·Status: RECRUITING

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

NCT03662204 ·Status: COMPLETED